The effect of education on all-cause mortality risk in adults on a global scale.
Study reveals genetic factors affecting birth sex ratios
Each year, roughly the same numbers of boys and girls are born.
Each year, roughly the same numbers of boys and girls are born.
The Phase III FURVENT trial of furmonertinib to treat first-line NSCLC with EGFR exon 20 insertion mutations is enrolling subjects. Credit: create jobs 51 /
Albumedix Ltd., a recognized global leader in Recombinant Human Albumin (rHA), specializing in the enablement of advanced therapies and biopharmaceuticals, today announces the expansion of its existing collaboration with